Diagnosis,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 3, 2024
Diagnostic
scope
is
the
range
of
diagnoses
found
in
a
clinical
setting.
Although
diagnostic
an
essential
feature
training
and
evaluating
artificial
intelligence
(AI)
systems
to
promote
excellence,
its
impact
on
AI
process
remains
under-explored.
Journal of the American Medical Informatics Association,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 7, 2025
Abstract
The
primary
practice
of
healthcare
artificial
intelligence
(AI)
starts
with
model
development,
often
using
state-of-the-art
AI,
retrospectively
evaluated
metrics
lifted
from
the
AI
literature
like
AUROC
and
DICE
score.
However,
good
performance
on
these
may
not
translate
to
improved
clinical
outcomes.
Instead,
we
argue
for
a
better
development
pipeline
constructed
by
working
backward
end
goal
positively
impacting
clinically
relevant
outcomes
leading
considerations
causality
in
validation,
subsequently
pipeline.
Healthcare
should
be
“actionable,”
change
actions
induced
improve
Quantifying
effect
changes
is
causal
inference.
evaluation,
validation
therefore
account
intervening
Using
lens,
make
recommendations
key
stakeholders
at
various
stages
Our
aim
increase
positive
impact
Annals of Internal Medicine,
Journal Year:
2024,
Volume and Issue:
177(7), P. 964 - 967
Published: June 3, 2024
Internal
medicine
physicians
are
increasingly
interacting
with
systems
that
implement
artificial
intelligence
(AI)
and
machine
learning
(ML)
technologies.
Some
health
care
even
developing
their
own
AI
models,
both
within
outside
of
electronic
record
(EHR)
systems.
These
technologies
have
various
applications
throughout
the
provision
care,
such
as
clinical
documentation,
diagnostic
image
processing,
decision
support.
With
growing
availability
vast
amounts
patient
data
unprecedented
levels
clinician
burnout,
proliferation
these
is
cautiously
welcomed
by
some
physicians.
Others
think
it
presents
challenges
to
patient-physician
relationship
professional
integrity
dispositions
understandable,
given
"black
box"
nature
for
which
specifications
development
methods
can
be
closely
guarded
or
proprietary,
along
relative
lagging
absence
appropriate
regulatory
scrutiny
validation.
This
American
College
Physicians
(ACP)
position
paper
describes
College's
foundational
positions
recommendations
regarding
use
AI-
ML-enabled
tools
in
care.
Many
recommendations,
those
related
patient-centeredness,
privacy,
transparency,
founded
on
principles
ACP
Ethics
Manual.
They
also
derived
from
considerations
safety
effectiveness
well
potential
consequences
disparities.
The
calls
more
research
ethical
implications
effects
well-being.
Clinical Pharmacology & Therapeutics,
Journal Year:
2024,
Volume and Issue:
116(3), P. 619 - 636
Published: July 11, 2024
Precision
dosing,
the
tailoring
of
drug
doses
to
optimize
therapeutic
benefits
and
minimize
risks
in
each
patient,
is
essential
for
drugs
with
a
narrow
window
severe
adverse
effects.
Adaptive
dosing
strategies
extend
precision
concept
time-varying
treatments
which
require
sequential
dose
adjustments
based
on
evolving
patient
conditions.
Reinforcement
learning
(RL)
naturally
fits
this
paradigm:
it
perfectly
mimics
decision-making
process
where
clinicians
adapt
administration
response
evolution
monitoring.
This
paper
aims
investigate
potentiality
coupling
RL
population
PK/PD
models
develop
algorithms,
reviewing
most
relevant
works
field.
Case
studies
were
integrated
within
algorithms
as
simulation
engine
predict
consequences
any
action
have
been
considered
discussed.
They
mainly
concern
propofol-induced
anesthesia,
anticoagulant
therapy
warfarin
variety
anticancer
differing
administered
agents
and/or
monitored
biomarkers.
The
resulted
picture
highlights
certain
heterogeneity
terms
approaches,
applied
methodologies,
degree
adherence
clinical
domain.
In
addition,
tutorial
how
problem
should
be
formulated
key
elements
composing
framework
(i.e.,
system
state,
agent
actions
reward
function),
could
enhance
approaches
proposed
readers
interested
delving
Overall,
integration
into
RL-framework
holds
great
promise
but
further
investigations
advancements
are
still
needed
address
current
limitations
applicability
methodology
requiring
adaptive
strategies.
npj Digital Medicine,
Journal Year:
2025,
Volume and Issue:
8(1)
Published: Feb. 6, 2025
The
European
CORE–MD
consortium
(Coordinating
Research
and
Evidence
for
Medical
Devices)
proposes
a
score
medical
devices
incorporating
artificial
intelligence
or
machine
learning
algorithms.
Its
domains
are
summarised
as
valid
clinical
association,
technical
performance,
performance.
High
scores
indicate
that
extensive
investigations
should
be
undertaken
before
regulatory
approval,
whereas
lower
which
less
pre-market
evaluation
may
balanced
by
more
post-market
evidence.
Global Clinical Engineering Journal,
Journal Year:
2025,
Volume and Issue:
7(1), P. 5 - 16
Published: March 31, 2025
In
an
era
of
rapid
digital
transformation,
patient
safety
is
increasingly
intertwined
with
technological
advancements
in
healthcare.
This
article
explores
the
dual
nature
these
innovations,
where
tools
like
telemedicine,
artificial
intelligence
(AI),
and
electronic
health
records
(EHRs)
offer
significant
potential
to
enhance
care
delivery
introduce
new
risks
such
as
algorithmic
bias,
cybersecurity
threats,
challenges
minimizing
risks.
A
balanced
approach
focusing
on
robust
protocols
continuous
learning
required
ensure
technology
enhancement
without
undermining
safety.
The
paper
aims
advance
discourse
integrating
patient-centric
care,
proposing
future
research
policy
development
strategies
sustain
a
high
standard
healthcare
environment.
JAMA Network Open,
Journal Year:
2025,
Volume and Issue:
8(4), P. e258052 - e258052
Published: April 30, 2025
Importance
The
primary
objective
of
any
newly
developed
medical
device
using
artificial
intelligence
(AI)
is
to
ensure
its
safe
and
effective
use
in
broader
clinical
practice.
Objective
To
evaluate
key
characteristics
AI-enabled
devices
approved
by
the
US
Food
Drug
Administration
(FDA)
that
are
relevant
their
generalizability
reported
public
domain.
Design,
Setting,
Participants
This
cross-sectional
study
collected
information
on
all
received
FDA
approval
were
listed
website
as
August
31,
2024.
Main
Outcomes
Measures
For
each
device,
detailed
for
at
time
summarized,
specifically
examining
evaluation
aspects,
such
presence
design
performance
studies,
availability
discriminatory
metrics,
age-
sex-specific
data.
Results
In
total,
903
FDA-approved
analyzed,
most
which
became
available
last
decade.
primarily
related
specialties
radiology
(692
[76.6.%]),
cardiovascular
medicine
(91
[10.1%]),
neurology
(29
[3.2%]).
Most
software
only
(664
[73.5%]),
6
(0.7%)
implantable.
Detailed
descriptions
development
absent
from
publicly
provided
summaries.
Clinical
studies
505
(55.9%),
while
218
(24.1%)
explicitly
stated
no
conducted.
Retrospective
designs
common
(193
[38.2%]),
with
41
(8.1%)
being
prospective
12
(2.4%)
randomized.
Discriminatory
metrics
200
summaries
(sensitivity:
183
[36.2%];
specificity:
176
[34.9%];
area
under
curve:
82
[16.2%]).
Among
less
than
one-third
data
(145
[28.7%]),
117
(23.2%)
addressed
age-related
subgroups.
Conclusions
Relevance
this
study,
approximately
half
devices,
yet
was
often
insufficient
a
comprehensive
assessment
generalizability,
emphasizing
need
ongoing
monitoring
regular
re-evaluation
identify
address
unexpected
changes
during
use.